ASCO’s Peter Yu, MD, and Priority Health’s Burton VanderLaan, MD, to Give Keynotes at AJMCLive Event
Bringing stakeholders together is the mission of AJMCLive, the meeting series of The American Journal of Managed Care. It’s reflected in the two keynote speakers for Patient-Centered Oncology Care on Nov. 14: a leader of physicians, Peter Yu, MD, the current president of ASCO; and a leader among payers, Burton VanderLaan, MD, FACP, medical director of Priority Health.
First-Ever Diagnostic Test for T1DM Receives FDA Approval
The test, the first-ever to distinguish the type 1 form of diabetes, could detect the ZnT8 autoantibody in 65 percent of the samples from patients with diagnosed type 1 diabetes and gave false positive results in less than two percent of the samples from patients diagnosed with other disease.
Limit Patient Cost-Sharing: States Tell Payers
Insurers are trapped between pharmaceutical companies developing increasingly expensive drug treatments, and states that want to reduce the patient-burden of co-pays. Additionally, states like New York and Alaska have banned payers from using specialty formularies.